What's new

The ADAPT trial will evaluate a new biomarker blood test in NHS memory clinics, aiming to improve the speed and accuracy of diagnosis.

Developed by IBMS with Roche Diagnostics UK, with support from RCPath and LabMed, the report provides actionable guidance to improve standards, workforce capability and patient outcomes.

Swift action by laboratory teams has been crucial in identifying faults, managing patient recalls, and ensuring service safety

With input from the IBMS, the new framework maps career pathways across healthcare science.

IBMS issues an update on response to the profession’s issues affecting visa renewals for biomedical scientists in the UK

David Wells discusses the recent Women’s Cancer Screening Taskforce report

IBMS responds to widely reported BMJ studies into at home test kits.

The BJBS now holds an Impact Factor of 4.6, placing it among the top journals in its field.

IBMS supports regulatory reform proposed in Phase 2 of the Independent Inquiry into the issues raised by the David Fuller case

IBMS members took part in Pride in London and Pride Cymru in Cardiff once again this year

Promoting patient safety and best practice in transfusion care

Dermatopathology and Associated Laboratory Investigations in the Study of Skin Disease

The winners of the IBMS Awards 2025 were announced at a dazzling showcase on Friday 4th July, bringing together some of the most inspiring professionals in biomedical science for a truly unforgettable evening at The Brewery in Central London

Document clarifies the role of biomedical scientists in warfarin monitoring and dosage decisions

New report highlights solutions for earlier diagnosis

Pathology’s essential role within the wider transformation of health and care

Our new website is designed to improve how we support members, deliver qualifications and promote biomedical science.